Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Avenue Therapeutics Inc

Current price
3.71 USD -0.04 USD (-1.07%)
Last closed 3.62 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 458 029 USD
Yield for 12 month +234.23 %
21.11.2021 - 28.11.2021

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Address: 1111 Kane Concourse, Tampa, FL, United States, 33154

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

56.25 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ATXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Operating Margin TTM
PE Ratio
Return On Assets TTM -209.03 %
PEG Ratio
Return On Equity TTM -535.1 %
Wall Street Target Price 56.25 USD
Revenue TTM
Book Value 4.64 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1 145.72 USD
Diluted Eps TTM -1 145.72 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -76.3 %
Profit Margin

Dividend Analytics ATXI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ATXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:75
Payout Ratio
Last Split Date 26.04.2024
Dividend Date

Stock Valuation ATXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 17.9856
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.4154
Price Book MRQ 3.7938

Financials ATXI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ATXI

For 52 weeks

3.52 USD 93.75 USD
50 Day MA 8.01 USD
Shares Short Prior Month 17 132
200 Day MA 23.42 USD
Short Ratio 0.34
Shares Short 46 102
Short Percent 2.88 %

Dynamics of changes in the value of assets




430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds



14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics